Andrew J Spillane
5PUBLICATIONS
35CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jan 28, 2026
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial.Lotte L Hoeijmakers, Petros Dimitriadis, Steven C M A Wijnen
|Jun 21, 2024
Neoadjuvant pembrolizumab, dabrafenib and trametinib in BRAFV600-mutant resectable melanoma: the randomized phase 2 NeoTrio trial.Georgina V Long, Matteo S Carlino, George Au-Yeung
|Jun 06, 2022
Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial.Irene L M Reijers, Alexander M Menzies, Alexander C J van Akkooi
|Feb 09, 2021
Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).Alexander M Menzies, Rodabe N Amaria, Elisa A Rozeman
|Feb 09, 2021
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma.E A Rozeman, E P Hoefsmit, I L M Reijers
Pageof 1
Frequent Collaborators
5 joint publications
Robyn P M Saw
5 joint publications
Richard A Scolyer
4 joint publications
Kerwin F Shannon
4 joint publications
Georgina V Long
4 joint publications
Christian U Blank
3 joint publications
John B A G Haanen
2 joint publications
Petros Dimitriadis
2 joint publications
Jos A van der Hage
2 joint publications
Geke A P Hospers
2 joint publications
Serigne N Lo
